Top Manufacturing Companies in Minneapolis, MN (37)

Strong Revenue Growth: Net sales increased 15.7% in 2025 to about $6.4B, then rose 15.6% in Q1 2026 and 22.2% in Q2 2026, extending to 13 consecutive quarters of double‑digit growth. Management raised 2026 guidance to 16–17% net‑sales growth on the back of this acceleration.

Profitability: Net income rose 59.9% in 2025, with adjusted EBITDA up 19.4% to roughly $1.14B. In Q2 2026, adjusted net income grew about 29% and adjusted EBITDA ~19%, even as the company navigated mixed margin dynamics.

Market Expansion: International net sales grew 20.8% in 2025 and accelerated 31.6% in Q1 2026 and 36.6% in Q2 2026, with strong results in the UK, Europe, and Latin America. The company is broadening its total addressable market by adding new product categories and entering new geographies.

Strong Revenue Growth: Reported back-to-back record years in 2024 and 2025 with rising order intake and a solid backlog indicate meaningful top-line momentum and visibility. Updates through late 2025 highlight double-digit sales increases across multiple periods, supporting an ongoing growth trajectory.

Profitability: Management disclosures point to margin expansion and significantly higher EBITDA and cash flow in 2025 versus 2024, aided by stronger mix in Pharma and services. Portfolio actions and integration of Telstar are cited as contributors to improved earnings quality.

Strong Market Position & Advantage: Sources consistently place Syntegon in the top cohort of global pharma packaging equipment vendors with a large installed base and leadership reputation, reinforced by scale and heritage from Bosch Packaging Technology. Record performance, industry awards, and strategic acquisitions deepen capabilities in aseptic/fill-finish and support competitive advantage.

Strong Market Position & Advantage: Industry recognitions (e.g., top rankings and inclusion on leading-company lists) and a broad national footprint serving over ten thousand facilities suggest a durable competitive position.

Strong Revenue Growth: Multi‑year top‑line increases, including successive annual and quarterly gains through 2023, indicate continuing demand across core service lines.

Investor Backing & Capital Strength: The go‑private acquisition by THL provides sponsor support and financial flexibility to pursue long‑term investments and strategic initiatives.

Strong Market Position & Advantage: Polaris reports No. 1 share in North American off‑road vehicles and leadership in pontoons, with a top‑two position in snowmobiles. Trade coverage and management commentary highlight share gains across ORV, snow, and marine in 2025 despite macro and tariff headwinds.

Resilient & Sustainable Growth: After a flat 2025, late‑2025 and Q1‑2026 sales grew year over year (approximately 9% in Q4 2025 and 8% in Q1 2026) while guidance was reaffirmed. Dealer inventories were “right‑sized,” positioning cleaner sell‑through if demand holds.

Future-Ready Strategy: The 2026 separation of Indian Motorcycle concentrates resources on core ORV, snow, and marine categories where leadership is strongest. Management is also working to mitigate tariffs (e.g., reducing China‑sourced content) and sustain category leadership to improve resilience.

Strong Market Position & Advantage: The company is broadly regarded as a leader in polymer-based medical components and catheter technologies, serving many major OEMs and frequently making tier-one shortlists. DuPont’s 2023 acquisition explicitly described it as a recognized leader, reinforcing perceived competitive advantage.

Market Expansion: Recent moves include facility expansions and capability additions in Costa Rica, Minneapolis, Pleasant Prairie, Sandy, and Wall, increasing cleanroom space, extrusion lines, and catheter assembly capacity. These upgrades aim to raise throughput, shorten lead times, and strengthen supply resilience across key medtech hubs.

Investor Backing & Capital Strength: DuPont’s $1.75B acquisition and subsequent addition of Donatelle integrate Spectrum into a larger healthcare platform with materials synergies and balance-sheet support. Ongoing site investments under DuPont indicate continued capital commitment to scale and capability growth.

Strong Market Position & Advantage: Category‑leading franchises like Trojan, Batiste, Waterpik, and a top‑two TheraBreath underpin share gains cited in late 2025 and Q1 2026. Leadership is concentrated by category, supporting defensible positions in chosen niches.

Innovation-Driven Growth: Recent launches such as ARM & HAMMER Power Sheets, TheraBreath extensions, and a Trojan refresh, alongside portfolio adds like Touchland, are credited with fueling above‑category growth and volume gains. Management indicates ongoing innovation will support 2026 organic growth and sustained share momentum.

Profitability: Margins expanded and EPS increased in recent periods, with guidance calling for further improvement in 2026. Consistent profitability and scale enable continued brand investment and bolt‑on M&A.

Profitability: Operating margin of 26.7% and record 2025 net earnings alongside consistently high ROIC indicate strong profitability and earnings quality. A rebound in Q4 with double-digit operating earnings growth underscores margin strength.

Strong Market Position & Advantage: A focus on specialized, difficult-to-handle fluids in niche applications creates a protective moat with limited direct competition. Record sales and leadership across contractor and industrial segments reinforce category strength.

Investor Backing & Capital Strength: A near-zero debt-to-equity ratio and robust operating cash generation reflect a fortress balance sheet that supports investment and M&A. Recognition among top industrial stocks by institutional investors signals durable external confidence.

Strong Market Position & Advantage: Evidence indicates IPG is widely viewed as the leader in high‑power fiber laser sources, supported by deep vertical integration and a broad global footprint. Consistent product introductions and industry recognition reinforce this durable positioning.

Innovation-Driven Growth: New platforms across welding, additive manufacturing, cleaning, micromachining, medical, and defense (e.g., compact counter‑drone systems) point to ongoing R&D momentum. Awards and recent platform launches suggest technology leadership is translating into growth opportunities.

Diversified Revenue Streams: Recent quarters highlight growth beyond legacy cutting into welding, additive, micromachining, cleaning, and medical applications. The rising contribution from newer applications and acquisitions indicates a more balanced mix across end markets.

Strong Market Position & Advantage: Feedback suggests Integer is broadly regarded as a top‑tier CDMO, with particular leadership across cardio/vascular and CRM/neuromodulation and consistent recognition in industry roundups. Analyst commentary also frames the company as a scaled consolidator capable of above‑market organic growth in a consolidating outsourcing market.

Strong Revenue Growth: Feedback suggests 2025 was a solid growth year with sales up 8% to about $1.854B and Q4 2025 sales up 5%, alongside double‑digit expansion in adjusted operating income and EBITDA. Multi‑year context shows sustained growth through 2024–2025 before the current pause.

Future-Ready Strategy: Feedback suggests the company sharpened focus by divesting its non‑medical Electrochem business and investing in high‑growth capabilities such as coatings (Precision Coating, VSi Parylene, Biocoat assets). Management also targets a return to 200 bps above‑market organic growth in 2027 as current headwinds abate.

Strong Revenue Growth: Recent results indicate record quarterly revenue and year-over-year increases in 2024, signaling solid top-line momentum. Company guidance points to continued expansion supported by both acquisitions and organic contributions.

Healthy Cash Flow: Record operating cash flow in 2024 suggests robust cash generation to support investment and integration. Strong adjusted EBITDA trends reinforce the company’s capacity to fund growth initiatives.

Future-Ready Strategy: The Snap One acquisition and the planned ADI spin-off indicate a deliberate portfolio strategy to sharpen focus and enhance competitive positioning. Digital transformation and new connected products further align the business with evolving smart-home standards.

Strong Revenue Growth: Revenue estimates have risen across sources and leadership described a “record-setting year,” indicating accelerating top-line momentum despite private-company opacity.

Market Expansion: Acquisitions (e.g., a Chicago concrete science lab and Southeast add-ons) and entry into states like Texas, Kansas, Georgia, and South Carolina indicate a widening footprint and capability set.

Leadership Stability: A long-tenured CEO grew the firm substantially, and the 2024 leadership transition was framed around continued growth and client focus, suggesting continuity in strategy and governance.

Strong Market Position & Advantage: Sherwin-Williams is positioned as the largest global paints and coatings company, with record sales and a dominant North American pro-channel presence supported by a vast company-owned store network. Brand leadership and scale reinforce pricing, service, and mix advantages.

Market Expansion: The company is expanding through acquisitions and footprint growth, including the Suvinil deal in Brazil and continued net store additions. These moves extend leadership into growth markets and broaden regional exposure.

Healthy Cash Flow: Strong cash generation is evidenced by high free cash flow conversion and rising net operating cash despite uneven demand. This supports ongoing investment, M&A integration, and shareholder returns.

Strong Market Position & Advantage: Element is positioned as a leader in aerospace and materials/product-qualification testing, underpinned by one of the industry’s highest counts of Nadcap-accredited labs and extensive OEM approvals. Its 270+ labs, 8,300+ technical staff, and broad accreditations across safety‑critical sectors reinforce scale and credibility.

Market Expansion: The network has expanded from 200+ labs and ~7,000 staff in 2022 to 270+ labs and 8,300+ colleagues, complemented by acquisitions such as NTS (2022), ISS (2024), CTK/NCT (2023), and CETECOM (2025). New recognitions (e.g., UK NRTL for U.S. hazardous locations) and capability investments in hydrogen, nuclear, and fire testing broaden addressable markets.

Innovation-Driven Growth: Recent initiatives like blockchain‑verified test reports and expanded connected‑tech/EMC capabilities indicate ongoing digital and technical productization. Added accreditations (e.g., FDA ASCA) and OEM program wins signal traction in higher‑value, regulated niches.